“The inaugural meeting of the Health Finance and Investment Forum 2012 has clearly demonstrated that investment in health requires an efficient, transparent and well governed management culture which provides the best available and preventive and curative health service – accessible and affordable for every single individual.” Siegfried Walch, Prof. for Health & Social Management, Management Center Innsbruck, Austria

Health Business Community - Working Group - Medical Technology and Equipment

After the incredible success of the first Peer-Roundtable, the Health Finance and Investment Forum (HFIF) in collaboration with The Egyptian Junior Business Association (EJB) cordially invite you to the Working Group "Medical Technology & Equipment" under the umbrella of the Health Business Community (HBC).

In order for the community to be impactful and develop as an Opportunity Tank, follow up is vital. To ensure arriving at constructive steps regarding HBC's first topic, the Working Group “Medical Technology & Equipment” was created

The key topics for the Working Group as identified by the participants in the first meeting are:

- Government affairs, legislative reforms and the business environment

- Business growth and access to finance

The following Roundtable will define the action points of the Working Group for the year 2015 and dig deeper into these topics.

May 27th, 2015, The Health Finance and Investment Forum (HFIF) in collaboration with The Egyptian Junior Business Association (EJB) cordially invite you to the Working Group “Medical Technology & Equipment”

Feb 10th, 2015, The Health Finance and Investment Forum (HFIF) in collaboration with The Egyptian Junior Business Association (EJB) cordially invited you to the first Peer Roundtable under the umbrella of the Health Business Community.

April 3rd, 2014. The HFIF in cooperation with Pharmaconex, EPEA, the Egyptian Industrial Chamber of Pharmaceuticals & the Syndicate of Toll Pharmaceutical Manufacturing Companies hosted a VIP event at the interface of finance and pharma.